US 9359418
Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use
granted A61KA61K38/00A61P
Quick answer
US patent 9359418 (Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/00, A61P, A61P1/18, A61P19/02